Skip to main content

Table 2 Multivariable analyses of factors associated with initiation and intensification of lipid-lowering and antihypertensive drug therapy

From: Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998–2004: a longitudinal observational study

 

Lipid-lowering drug therapy

Antihypertensive drug therapy

 

Initiation

Intensification

Initiation

Intensification

 

OR*(95% CI)

OR(95% CI)

OR(95% CI)

OR(95% CI)

Age (per 10 years)

0.7 (0.6–0.8)

-

1.2 (1.1–1.3)

1.1 (1.0–1.2)

Gender

-

-

-

-

HbA1c (%)

-

-

0.9 (0.8–1.0)

-

Systolic blood pressure (per 10 mmHg)

1.1 (1.0–1.1)

-

1.3 (1.2–1.4)

1.1 (1.1–1.2)

Diastolic blood pressure (per 10 mmHg)

-

-

1.2 (1.0–1.4)

1.1 (1.0–1.2)

TC/HDL ratio

1.8 (1.6–1.9)

1.3 (1.1–1.5)

1.2 (1.1–1.3)

-

History of MI/AP

1.9 (1.4–2.5)

-

2.3 (1.6–3.3)

-

Year of screening

1.3 (1.2–1.4)

0.9 (0.8–1.0)

1.1 (1.1–1.2)

1.1(1.1–1.1)

  1. * Additionally adjusted for body mass index. OR, odds ratio; HbA1c, haemoglobin A1c; TC, total cholesterol; HDL, high-density lipoprotein; MI, myocardial infarction; AP, angina pectoris.